Comparison Neuphoria Therapeutics (NEUP) with Competitors
Neuphoria Therapeutics (NEUP) industry is Biotechnology.
Profit Margin
NEUP75.08%
Industry-0.77%
Upside+75.85%
Operating Margin
NEUP79.85%
Industry-2055.25%
Upside+2135.10%
Free Cash Flow Yield
NEUP-90.62%
Industry-1.75%
Upside-88.87%
P/E
NEUP-0.85
Industry-20.52
Upside+1966.94%
P/S
NEUP1.70
Industry10.01
Upside-83.01%
P/B
NEUP0.66
Industry5.15
Upside-87.25%